rdf:type |
|
lifeskim:mentions |
umls-concept:C0017185,
umls-concept:C0086418,
umls-concept:C0169101,
umls-concept:C0243077,
umls-concept:C0245662,
umls-concept:C0301625,
umls-concept:C0431085,
umls-concept:C0441889,
umls-concept:C0675974,
umls-concept:C0681205,
umls-concept:C1533691,
umls-concept:C1539477,
umls-concept:C1550555,
umls-concept:C1879547
|
pubmed:issue |
9
|
pubmed:dateCreated |
2008-9-15
|
pubmed:abstractText |
Prior studies have noted that inhibitors of mitogen-activated protein kinase (MAPK) kinase 1/2 (MEK1/2) enhanced geldanamycin lethality in malignant hematopoietic cells by promoting mitochondrial dysfunction. The present studies focused on defining the mechanism(s) by which these agents altered survival in carcinoma cells. MEK1/2 inhibitors [PD184352; AZD6244 (ARRY-142886)] interacted in a synergistic manner with geldanamycins [17-allylamino-17-demethoxygeldanamycin (17AAG) and 17-dimethylaminoethylamino-17-demethoxy-geldanamycin] to kill hepatoma and pancreatic carcinoma cells that correlated with inactivation of extracellular signal-regulated kinase 1/2 and AKT and with activation of p38 MAPK; p38 MAPK activation was reactive oxygen species dependent. Treatment of cells with MEK1/2 inhibitors and 17AAG reduced expression of c-FLIP-s that was mechanistically connected to loss of MEK1/2 and AKT function; inhibition of caspase-8 or overexpression of c-FLIP-s abolished cell killing by MEK1/2 inhibitors and 17AAG. Treatment of cells with MEK1/2 inhibitors and 17AAG caused a p38 MAPK-dependent plasma membrane clustering of CD95 without altering the levels or cleavage of FAS ligand. In parallel, treatment of cells with MEK1/2 inhibitors and 17AAG caused a p38 MAPK-dependent association of caspase-8 with CD95. Inhibition of p38 MAPK or knockdown of BID, FAS-associated death domain, or CD95 expression suppressed MEK1/2 inhibitor and 17AAG lethality. Similar correlative data were obtained using a xenograft flank tumor model system. Our data show that treatment of tumor cells with MEK1/2 inhibitors and 17AAG induces activation of the extrinsic pathway and that suppression of c-FLIP-s expression is [Mol Cancer Ther 2008;7(9):2633-48].
|
pubmed:grant |
http://linkedlifedata.com/resource/pubmed/grant/P01 CA104177-030002,
http://linkedlifedata.com/resource/pubmed/grant/P01-CA104177,
http://linkedlifedata.com/resource/pubmed/grant/P01-NS031492,
http://linkedlifedata.com/resource/pubmed/grant/R01 CA108520-03,
http://linkedlifedata.com/resource/pubmed/grant/R01 DK052825-09,
http://linkedlifedata.com/resource/pubmed/grant/R01-CA097318,
http://linkedlifedata.com/resource/pubmed/grant/R01-CA098172,
http://linkedlifedata.com/resource/pubmed/grant/R01-CA108325,
http://linkedlifedata.com/resource/pubmed/grant/R01-CA63753,
http://linkedlifedata.com/resource/pubmed/grant/R01-CA77141,
http://linkedlifedata.com/resource/pubmed/grant/R01-DK52825
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/18790746-11280726,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18790746-11553704,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18790746-11679961,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18790746-12623837,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18790746-12646560,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18790746-12652655,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18790746-12673720,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18790746-12676580,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18790746-12692057,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18790746-12697808,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18790746-12792650,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18790746-12947395,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18790746-14508491,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18790746-14613031,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18790746-14660582,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18790746-15110178,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18790746-15243584,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18790746-15299085,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18790746-15382121,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18790746-15483017,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18790746-15542843,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18790746-15608678,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18790746-15761078,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18790746-15774780,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18790746-15867239,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18790746-15955734,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18790746-15961763,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18790746-15989551,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18790746-16009947,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18790746-16109713,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18790746-16319524,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18790746-16428504,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18790746-16441226,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18790746-16609040,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18790746-17237274,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18790746-17303086,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18790746-17308059,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18790746-17363476,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18790746-17382893,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18790746-17511024,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18790746-17525527,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18790746-17534891,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18790746-17652623,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18790746-17699718,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18790746-5459626,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18790746-7731990,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18790746-9020108,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18790746-9782009
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/17-(allylamino)-17-demethoxygeldanam...,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD95,
http://linkedlifedata.com/resource/pubmed/chemical/Apoptosis Regulatory Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Benzoquinones,
http://linkedlifedata.com/resource/pubmed/chemical/CASP8 and FADD-Like Apoptosis...,
http://linkedlifedata.com/resource/pubmed/chemical/Lactams, Macrocyclic,
http://linkedlifedata.com/resource/pubmed/chemical/Mitogen-Activated Protein Kinase...,
http://linkedlifedata.com/resource/pubmed/chemical/Protein Kinase Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-akt,
http://linkedlifedata.com/resource/pubmed/chemical/Reactive Oxygen Species,
http://linkedlifedata.com/resource/pubmed/chemical/p38 Mitogen-Activated Protein...
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1535-7163
|
pubmed:author |
|